Head-to-head · WeighScore
Kongo vs Piper
By GLP-1 ScorecardUpdated
Score comparison
Kongo has the higher recorded score — 83.8/100 to 81.9/100, but only just.
Kongo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded injection plans with written support; confirm the charge, supplied quantity and renewal terms. Piper is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Kongo review and the Piper review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Kongo vs Pomegranate Health and Lavender Sky Health vs Piper compare each of them with another graded program, and the list of alternatives to Kongo ranks the programs closest to Kongo on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the yourEra review covers one graded close to these two, at 83.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Kongo | Piper |
|---|---|---|
| WeighScore | 83.8/100 | 81.9/100 |
| Grade | B | B− |
| Site position | #19 | #29 |
| Semaglutide | $109 one-month plan or $285 every three months advertised; confirm selected charge and supply. | $179 monthly; $135/month equivalent with six months prepaid. |
| Tirzepatide | $209 one-month or $387 three-month plan advertised; confirm selected charge and supply. | $279/mo month-to-month; $199/mo equivalent requires six months and $1,194 prepaid. |
| Coverage | All 50 advertised; confirm treatment-specific state availability. | All-state access claimed; confirm individual eligibility. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Regular one-month and prepaid totals published
- Medication, care, supplies and shipping advertised included
- Portal cancellation and clinical messaging
What to consider
- Refund and refill cutoffs need confirmation
- Operator and footer entities need clarification
- Assigned clinician and pharmacy not established
- Telephone support marked coming soon
Strengths
- Price FAQs distinguish monthly and prepaid plans.
- All-state access is advertised; individual eligibility needs confirmation.
- Advertises compounded injectable semaglutide and tirzepatide.
What to consider
- Assigned clinicians and dispensing facilities need confirmation.
- Refund cutoffs differ across public pages.
- Confirm the selected monitoring, billing and supply schedule.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.